Edmund Harrigan insider trades

Open-market stock purchases and sales by Edmund Harrigan, Director at Incyte Corp, from SEC Form 4 filings since Nov 25, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -11%.

Recent trades

DateStockTradeValue
Jun 8, 2026INCY Incyte CorpBought (not open market)—
Jun 8, 2026INCY Incyte CorpBought (not open market)—
May 29, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
May 29, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
May 29, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 31, 2026INCY Incyte CorpBought (not open market)$25.3K
Dec 31, 2025INCY Incyte CorpBought (not open market)$24.2K

Companies traded

  • INCY Incyte Corp: other filings, last Jun 8, 2026
  • ACAD Acadia Pharmaceuticals Inc: 1 buy, last May 29, 2026
  • PHAS PhaseBio Pharmaceuticals Inc: 1 buy, last May 19, 2023
  • KRTX Karuna Therapeutics, Inc: 3 sales, last Aug 12, 2020
  • BLCM Bellicum Pharmaceuticals, Inc: other filings, last Jun 13, 2019

Get free alerts when Edmund Harrigan files a new trade →